Here are relevant reports on : intelligent-landscape-design-market
-
Ophthalmology Drugs & Devices Market (Contact Lens, Optical Coherence Tomography (OCT) Scanner, IOL, Dry Eye, AMD, Glaucoma & Phacoemulsification) – Competitive Landscape & Global Forecasts To 2017
The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year.
- Published: August 2012
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Global Digital Signal Processors (DSP) Market by Intellectual Property (IP), Design Architecture & Applications (2011 – 2016)
The report analyzes the entire DSP industry’s value chain, giving a bird’s eye-view of all the major allied industry segments to the DSP industry. It discusses the markets of various allied industry segments such as EDA vendors, foundry players, fabless players, fab players, IP vendors and assembly testing and packaging vendors related to the global DSP market. The global DSP intellectual property market is classified and discussed in detail with market estimates and forecasts for each IP segments.
- Published: February 2012
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market is projected to reach USD 72.29 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2025–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive Landscape
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
Fertigation & Chemigation Market by Agri Inputs (Fertilizers, Herbicides, Insecticides, & Fungicides), Application (Agriculture, Landscape, & Greenhouse), Crop Type, Irrigation Systems, & by Region - Global Trends and Forecast to 2020
The fertigation & chemigation market, in terms of value, is projected to reach around USD 42.2 Billion by 2020, at a CAGR of around 6.3% from 2015. The fertigation & chemigation market continues to grow due to high demand in most of the countries and intensive market opportunities. The market players are responding to these new opportunities by expanding their global presence and product lines. Fertigation & chemigation, on the basis of agri inputs, has been segmented into: fertilizer, herbicide, insecticide, and fungicide.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region - Global Forecast to 2030
The global collagen & gelatin market, valued at US$1203.9M in 2024, is forecasted to grow at a 5.8% CAGR, reaching US$1,295.5M by 2025 and US$1,671.3M by 2030. Globally, US is the largest market for collagen and gelatin and this trend is expected to continue during the forecast period
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Electrical Design Software Market - Global Forecast to 2028
The global Electrical Design Software market size is projected to reach XX.X billion USD by 2028 at a Compound Annual Growth Rate (CAGR) of XX.X% during the forecast period. Dassault Systemes, Siemens, Autodesk, ABB, Schneider Electric, SCADA Systems, ETAP, Cadmatic, Zuken, and Bentley are a few key players in the global electrical design software market.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
